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to 20% lower than planned. Most common anatomical areas 
not receiving 95% dose were vagina, obturator and external 
iliac nodes for both cases and superior nodal aspect for case 
1. The DVH below shows the gold standard PTV coverage for 
each centre’s RapidArc plan.  
 
 
Conclusion: This quality assurance exercise demonstrates 
that, using IMRT, CTV delineation variation leads to 
potentially clinically important PTV dosimetric variations. 
Therefore, as IMRT use increases, the importance of accurate 
target volume delineation also increases.  
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Purpose or Objective: The aim of the study is to report the 
most important problems found within the on-site dosimetry 
audits of radiotherapy centres. On-site audits of therapeutic 
units are performed by our institute after commissioning and 
acceptance test for each external radiotherapy and 
brachytherapy unit in the Czech Republic since 1997. They 
are performed with the same dosimetry equipment by the 
same persons to reduce the uncertainty in the results. The 
system of on-site audits includes the basic audit aimed at the 
verification of selected mechanical and dosimetric 
parameters, advanced audit to verify selected functions of 
TPS, and end-to-end audit to check the whole radiotherapy 
chain from planning to delivery. When high deviation is found 
(not only exceeding tolerance level), the auditors always try 
to find the reason, rectify the problem on-site, or give 
appropriate recommendations to the particular centre. The 
results of the audits are reported to the national regulatory 
body. 
 
Material and Methods: The results from on-site basic, 
advanced, and end-to-end audits have been reviewed and 
analysed. Statistical process control (SPC) has been 
performed where appropriate. 
 
Results: We report important errors that might lead to the 
radiological accident if not revealed by the on-site audit. In 
early years, the main typical errors were caused by incorrect 
input data in the TPS after the acceptance test. Of the main 
importance were: incorrect determination of dose rate for 
60Co unit; incorrect output factors or wedge factors; using 
ionisation data instead of dose data measured with ion 
chamber for electron beams; incorrect SSD for measurement; 
incorrect detector; not taking into account couch attenuation 
etc. These types of errors are not so frequent but still 
observable nowadays, regardless the high quantity of 
published recommendations and literature on that topic. 
Currently, with new algorithms implemented in the TPS, 
various errors were found due to the lack of training, in 
particular for Monte Carlo (MC) algorithms. The TPSs were 
not commissioned i.e. with MC input data used in clinical 
practice but with data calculated for highest accuracy to 
comply with the measurements. End-to-end audit enabled to 
reveal insufficient patient QA, inaccuracy in TPS calculations 
for non-reference material, incorrect CT numbers to RED 
calibration curves, not following the ICRU and other 
international reports. 
 
Conclusion: All the examples can serve as a learning system. 
In early years, the main cause of errors was a lack of time for 
measurements evaluation and verification. More recently, the 
other cause of the errors is a lack of time to get familiar with 
new equipment, especially with the software (TPS). In all 
cases, the errors were found at centres with a lack of clinical 
medical physicists with sufficient continual professional 
development.This work was supported by the project No. 
TB04SUJB001. 
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Purpose or Objective: 3D printing technology introduces the 
potential for improved accuracy of bolus in conforming to 
patients and may provide efficiency gains through automation 
of production based on planning CT data. The objectives of 
this study are i) to compare build-up depth dose 
characteristics of solid and flexible 3D printed bolus material 
to both Solid Water and standard sheet bolus material, ii) to 
assess the fit of 3D printed bolus to chestwall anatomy based 
on CT imaging compared to sheet bolus, and iii) to examine 
dosimetric accuracy of the treatment plan compared to OSLD 
measurements with 3D printed bolus. 
 
Material and Methods: Depth dose measurements were 
performed with a Markus parallel plate chamber for 
polylactic acid (PLA) and flexible (Ninjaflex) 3D printing 
materials, and results were compared to both standard sheet 
bolus (Superflab) and Solid Water. For three chestwall 
patients, ballistics gel molds of the chestwall were fabricated 
to produce spatially realistic phantoms with plasticity similar 
to that of tissue. 5 mm thick, 3D printed chestwall boluses 
were fabricated for these phantoms based on CT data. CT 
imaging was then used to assess conformity to the surface 
and presence of air cavities. Optically Stimulated 
Luminescent Dosimetry (OSLD) was used to measure dose 
under both 3D printed and sheet bolus at nine locations on 
the chestwall surface for typical field-in-field treatment 
deliveries. 
 
Results: In the build-up region, PLA and Ninjaflex bolus 
material exhibit similar depth dose characteristics. Both 
types of 3D bolus yield a greater dose compared to Solid 
Water, however differences remain below 5%. CT imaging of 
gel phantoms show an improved fitting of 3D printed bolus, 
with air cavities below the bolus reduced by 9% to 321% 
compared to standard sheet bolus. Treatment planning 
studies show better uniformity of skin dose for 3D printed 
bolus compared to sheet bolus, with the former giving a 
standard deviation of 1.8% compared to 4.2%. On average, 
the agreement of OSLD-measured to planned dose was similar 
between sheet bolus and 3D printed bolus, however standard 
sheet bolus shows greater variability in the measured-to-
planned dose ratio (15% range for sheet bolus compared to 6% 
for 3D printed bolus). 
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Conclusion: Rigid (PLA) and flexible (Ninjaflex) bolus 
materials provide build-up characteristics within 5% of Solid 
Water. When incorporated into treatment planning 
calculations, planned dose for 3D bolus agrees with OSLD 
measured dose to within 2% on average, and 3D printed bolus 
gives lower variability in the agreement of the delivered to 
planned dose. In summary, 3D printed chestwall bolus may be 
produced in an automated fashion and gives improved 
consistency of delivered dose accuracy compared to standard 
sheet bolus. 
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Purpose or Objective: Mitigating risks in radiotherapy is 
paramount for patient safety. A volumetric modulated arc 
therapy (VMAT) adapted to failure mode and effect analysis 
(FMEA) and implemented through workflow-integrated 
checklists is presented. This work is in line with efforts done 
by organizations to integrate a culture of patient safety into 
radiotherapy processes. 
 
Material and Methods: VMAT is currently being offered to our 
patients using RapidArc®, Eclipse® 11, Aria-11®, and 
TrueBeamTM; all by Varian Medical Systems (Palo Alto, CA). 
All systems went clinical in February 2013. Three months into 
the VMAT program, we realized our operation may be 
optimized by using the new Workflow feature introduced in 
Aria® version 11. Consequently, a workgroup consisting of 2 
physicists, 3 radiation oncologists, one radiation therapist 
and one IT was created to identify modes-of-failure in our 
VMAT planning and preparation process; and to implement a 
workflow that mitigates their risks. A process-centered risk 
analysis for VMAT employing FMEA was performed. Risk 
priority numbers (RPN) for occurrence, severity and 
detection, were assigned for identified modes of failure 
based on a simplified model of the AAPM TG100 scoring. 
FMEA for one task in our VMAT process (Figure 1) is presented 
as example in Table1. Mitigation actions were implemented 
into Aria-11® Workflow via integrated checklists where e-
signatures are enforced. Risk mitigation strategies employing 
redundancy, implementation of related policies-and-
procedures, documentation, and peer-review were hardwired 
into the VMAT process. 
 
Results: A VMAT workflow (Figure 1) was designed and 
included 114 potential-modes-of-failure distributed into 4 
groups: (1) 59 modes recurring redundantly, (2) 3 decision-
type modes forcing re-planning, (3) 33 recurring modes aimed 
for enhancing communication, and (4)19 modes occurring 
only once; some with residual RPN’s necessitating 
implementation of policies-and-procedures. In the 18 months 
period leading up to this study, more than 600 VMAT planning 
and preparation processes were delivered conforming to the 
workflow in Figure 1. No aberrations in treatments occurred. 
Shortcomings in e-chart preparations were virtually 
eliminated. 
 
Conclusion: An adaptation of the VMAT planning and 
preparation process to FMEA using the Aria-11® workflow was 
presented. Risk analysis was performed, and risk mitigation 
was achieved through hardwiring appropriate checklists into 
the VMAT planning tasks. The adaptation to FMEA resulted in 
marked improvements in patient safety, process control and 
process documentation. The presented workflow adaptation 
to FMEA could serve as a reference or model for clinics 
offering VMAT. 
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Purpose or Objective: The National Platform RT Head and 
Neck Cancer (HNC, Landelijk Platform Radiotherapie 
Hoofdhals Tumoren, LPRHHT) is a working party of the Dutch 
Society of Radiation Oncology, and is engaged in regulating 
and improving RT for HNC. One of the objectives of the 
LPRHHT is to evaluate the variation in treatment plan (TP) 
objectives and possibly improve treatment planning by 
increased organ at risk (OAR) sparing and reduction of 
variation between institutes. 
